Market Overview:
The infection control market is experiencing rapid growth, driven by rising incidence of healthcare-associated infections (hais), increasing focus on patient safety and stringent regulations, and continuous technological advancements and innovation. According to IMARC Group’s latest research publication, “Infection Control Market Report by Type (Equipment, Services, Consumables), End User (Hospitals and Clinics, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, and Others), and Region 2025–2033”, the global infection control market size reached USD 28.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 49.7 Billion by 2033, exhibiting a growth rate (CAGR)of 6.22% during 2025–2033.
This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.
Download a sample PDF of this report: https://www.imarcgroup.com/infection-control-market/requestsample
Our report includes:
- Market Dynamics
- Market Trends and Market Outlook
- Competitive Analysis
- Industry Segmentation
- Strategic Recommendations
Growth Factors in the Infection Control Market
- Rising Incidence of Healthcare-Associated Infections (HAIs)
The persistent and widespread challenge of Healthcare-Associated Infections (HAIs) is a primary catalyst for market expansion. These infections, often driven by invasive procedures and increasing antibiotic resistance, impose a substantial burden on healthcare systems globally. For instance, data from public health authorities in developed regions consistently show that up to 10% of patients in developing countries and 7% in developed countries acquire at least one HAI while hospitalized. This high incidence necessitates the continuous and rigorous purchase of advanced disinfection products, sterilization equipment, and protective barriers. The economic cost is also acute, with surgical site infections alone costing healthcare systems billions annually. This constant threat fuels demand for comprehensive infection prevention strategies and solutions.
- Increasing Focus on Patient Safety and Stringent Regulations
Stricter government mandates and a heightened global emphasis on patient safety are compelling healthcare facilities to adopt sophisticated infection control protocols. Organizations like the World Health Organization (WHO) issue global strategies and guidelines to strengthen Infection Prevention and Control (IPC) programs, which are then reinforced by national policies. This regulatory push drives market activity. For example, mandatory public reporting of infection rates and financial penalties tied to high HAI rates—as seen in major healthcare markets like North America—motivate hospitals to invest heavily in advanced monitoring systems and automation. This environment fosters strategic collaborations and acquisitions, such as a major medical device company's recent acquisition of complementary sterilization container and instrumentation assets to expand its infection prevention portfolio.
- Continuous Technological Advancements and Innovation
The market is significantly propelled by the introduction of next-generation infection control technologies that offer improved efficacy and efficiency. Innovations are transforming sterilization, disinfection, and surveillance processes. Concrete examples include the rapid adoption of low-temperature hydrogen peroxide vapor systems for sterilizing heat-sensitive surgical instruments and the development of UV-C disinfection robots. These robots have shown the capability to eliminate over 99.9% of pathogens in a matter of minutes. Furthermore, continuous product improvements are seen in the consumables segment, which holds the largest revenue share in the market, driven by the persistent demand for single-use products like sterile wraps, drapes, and high-performance respirators.
Key Trends in the Infection Control Market
- Integration of AI and Automation in Surveillance
An emerging and impactful trend is the integration of Artificial Intelligence (AI) and automated systems for real-time infection surveillance. This moves infection control from reactive to predictive. AI-driven platforms leverage hospital data to track infection patterns, predict potential outbreaks, and guide optimal antibiotic selection, which is crucial for antibiotic stewardship efforts. Automated disinfection systems, such as UV-C and hydrogen peroxide vapor devices, are increasingly being deployed, offering documented reductions in infection rates. For instance, some healthcare facilities have reported a notable 30% reduction in difficult-to-treat infections after implementing automated terminal room disinfection combined with predictive monitoring tools.
- Expansion of Infection Control into Non-Healthcare Settings
The infection control market is experiencing significant growth outside of traditional hospital and clinic environments, extending into industries like food processing, hospitality, education, and public transportation. Heightened public awareness of germ transmission, amplified by recent global health events, has driven this demand. This trend is evident in the projected substantial growth for infection control solutions in non-healthcare sectors, with some estimates suggesting an increase of over 15% in the next few years. Companies are now tailoring professional-grade surface disinfectants and hand hygiene products for institutional use, and there is an increased deployment of air filtration and purification systems in public buildings to meet these new, elevated hygiene expectations.
- Shift Toward Sustainable and Eco-Friendly Products
Sustainability and environmental impact are becoming central considerations for purchasers of infection control products. This trend involves a rising demand for eco-friendly and reusable alternatives to traditional single-use consumables. Manufacturers are responding by developing biodegradable or plant-based disinfectants and wipes and exploring innovative, reusable materials for personal protective equipment (PPE), such as surgical gowns and sterilization wraps. The market is witnessing a focus on reducing reliance on ethylene oxide sterilization due to environmental concerns, leading to greater adoption of alternative low-temperature sterilization methods. This movement is driven by both regulatory pressures and the desire of large healthcare provider networks to meet their own organizational environmental, social, and governance (ESG) targets.
Leading Companies Operating in the Global Infection Control Industry:
- 3M Company
- Advanced Sterlization Products Services Inc. (Fortive Corporation)
- Belimed AG (Metall Zug)
- Cantel Medical Corp.
- Getinge AB
- Matachana
- Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.)
- MMM Münchener Medizin Mechanik GmbH
- Pal International
- Sterigenics U.S. LLC (Sotera Health Holdings LLC)
- Steris Corporation
- TSO3 Inc. (Stryker Corporation)
Infection Control Market Report Segmentation:
By Type:
Equipment
- Disinfectors
- Washers
- Flushers
- Ultrasonic Cleaners
- Sterilization Equipment
- Heat Sterilization
- Low Temperature Sterilization
- Radiation Sterilization
- Filtration-Based Sterilization
- Others
Services
- Contract Sterilization
- ETO Sterilization
- Gamma Sterilization
- E-Beam Sterilization
- Steam Sterilization
- Infectious Waste Disposal
Consumables
- Disinfectants
- Sterilization Consumables
- Personal Protective Equipment
- Others
Consumables hold the biggest market share as they are designed for ease of use and compatibility with existing healthcare protocols, thereby enhancing compliance with safety and hygiene standards.
By End User:
- Hospitals and Clinics
- Medical Device Companies
- Clinical Laboratories
- Pharmaceutical Companies
- Others
Hospitals and clinics represent the largest segment owing to the increasing number of patients seeking effective healthcare solutions.
Regional Insights:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
North America’s dominance in the infection control market is attributed to the rising emergence of novel pathogens.
Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel NoD) +91 120 433 0800
United States: +1-201971-6302
Comments (0)